Antifungal drug resistance in pathogenic fungi.

F Dromer, I Improvisi, M Lozano-Chiu, JH Rex… - Medical …, 1998 - europepmc.org
Failures of drug treatment in fungal infections combined with improvements in performances
and standardization of antifungal susceptibility testing have drawn attention to the problem …

International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database—the quality controlled standard tool for routine identification of …

…, L Delhaes, D Stubbe, F Dromer… - Medical …, 2015 - academic.oup.com
Human and animal fungal pathogens are a growing threat worldwide leading to emerging
infections and creating new risks for established ones. There is a growing need for a rapid …

Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

…, E Hart, A Lefort, P Ribaud, F Dromer… - Journal of …, 2006 - academic.oup.com
Candida spp. are responsible for most of the fungal infections in humans. Available since
1990, fluconazole is well established as a leading drug in the setting of prevention and …

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America

JR Perfect, WE Dismukes, F Dromer… - Clinical infectious …, 2010 - academic.oup.com
Cryptococcosis is a global invasive mycosis associated with significant morbidity and
mortality. These guidelines for its management have been built on the previous Infectious …

A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007)

…, M Huerre, D Bitar, F Dromer… - Clinical Infectious …, 2012 - academic.oup.com
Background. Mucormycosis is a deadly invasive fungal infection whose characteristics are
only partially understood. Methods. Data on mucormycosis obtained in France between 2005 …

EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal …

…, JP Donnelly, F Dromer… - Clinical …, 2008 - clinicalmicrobiologyandinfection …
Antifungal susceptibility tests are performed on fungi that cause disease, especially if they
belong to a species exhibiting resistance to commonly used antifungal agents. Antifungal …

[HTML][HTML] Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006

…, E Dannaoui, D Che, F Dromer… - Emerging infectious …, 2009 - ncbi.nlm.nih.gov
… (8) indicated a 1.8 M:F sex ratio and an average age of 38.8 years, versus 1.1 M:F sex
ratio and 57.1 years in our study, respectively. However, age distributions and underlying …

Evidence of a Role for Monocytes in Dissemination and Brain Invasion by Cryptococcus neoformans

…, S Daou, M Brigitte, F Chretien, F Dromer - Infection and …, 2009 - Am Soc Microbiol
… (F) Ratios of fungal loads measured in the spleens, lungs, and brains of depleted and
control mice (data are means ħ SD for three animals per group from three independent …

[HTML][HTML] Cryptococcal cell morphology affects host cell interactions and pathogenicity

…, NJ Baltes, F Chrétien, J Heitman, F Dromer… - PLoS …, 2010 - journals.plos.org
Cryptococcus neoformans is a common life-threatening human fungal pathogen. The size of
cryptococcal cells is typically 5 to 10 µm. Cell enlargement was observed in vivo, producing …

Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans

…, JW Fell, WCJ Hop, ECA Abeln, F Dromer… - …, 2001 - microbiologyresearch.org
… This latter isolate was one of the mating strains of F. bacillispora (Kwon-Chung, 1998R41
). The banding patterns of isolates belonging to this genotype were characterized by fewer …